Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High Grade Serous Carcinoma × ceralasertib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Endometrial Neoplasms 2 Carcinosarcoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Advanced Solid Tumours 2 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Lung Diseases 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 High Grade Serous Carcinoma 1 Fallopian Tube Neoplasms 1 Extensive Stage Small Cell Lung Cancer 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Endometrioid 1 Carcinoma, Bronchogenic 1 Bronchial Neoplasms 1

Interventions

olaparib 1 ceralasertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03462342 2026-03-17

CAPRI

University of Pennsylvania

Phase 2 Completed

High Grade Serous Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡